17 Patents
- US125527772026Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites
- US124599232025Tetrazole Containing Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - US12384753202517-beta-hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - US122811402025Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - US120180172024Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - US120062912024Processes for the Preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic Acid
Enanta Pharmaceuticals, Inc.
0 cites - 0 cites
- US119588792024Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- US118344362023Tetrazole Containing Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - US117186412023Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - US115603682023Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites - US115550322023Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites